137 related articles for article (PubMed ID: 22260330)
1. The course of hypercalciuria and related markers of bone metabolism parameters associated with corticosteroid treatment.
Duzen O; Erkoc R; Begenik H; Soyoral YU; Aldemir MN
Ren Fail; 2012; 34(3):338-42. PubMed ID: 22260330
[TBL] [Abstract][Full Text] [Related]
2. Biochemical markers of bone metabolism in infants and children under intravenous corticosteroid therapy.
Siomou E; Challa A; Tzoufi M; Papadopoulou ZL; Lapatsanis PD; Siamopoulou A
Calcif Tissue Int; 2003 Oct; 73(4):319-25. PubMed ID: 12874699
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
[TBL] [Abstract][Full Text] [Related]
4. A 7-week reduction in salt intake does not contribute to markers of bone metabolism in young healthy subjects.
Natri AM; Kärkkäinen MU; Ruusunen M; Puolanne E; Lamberg-Allardt C
Eur J Clin Nutr; 2005 Mar; 59(3):311-7. PubMed ID: 15674316
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
[TBL] [Abstract][Full Text] [Related]
6. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
7. High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton.
Cosman F; Nieves J; Herbert J; Shen V; Lindsay R
J Bone Miner Res; 1994 Jul; 9(7):1097-105. PubMed ID: 7942157
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
Uretmen S; Gol M; Cimrin D; Irmak E
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
[TBL] [Abstract][Full Text] [Related]
9. The influence of inhaled fluticasone on bone metabolism and calciuria in asthmatic children.
Ljuština-Pribić R; Stojanović V; Petrović S
J Aerosol Med Pulm Drug Deliv; 2011 Aug; 24(4):201-4. PubMed ID: 21476864
[TBL] [Abstract][Full Text] [Related]
10. Dietary calcium, sodium, phosphorus, and protein and bone metabolism in elderly Japanese women: a pilot study using the duplicate portion sampling method.
Nakamura K; Hori Y; Nashimoto M; Okuda Y; Miyazaki H; Kasai Y; Yamamoto M
Nutrition; 2004 Apr; 20(4):340-5. PubMed ID: 15043848
[TBL] [Abstract][Full Text] [Related]
11. Incidence of hypercalcemia, hypercalciuria and related factors in patients treated with recombinant human parathyroid hormone (1-84).
Luna-Cabrera F; Justicia-Rull EA; Caricol-Pérez MP; Soler-Vizán E; Mesa-López CM; Ruiz-Ruiz MA; De La Torre-López LE
Minerva Med; 2012 Apr; 103(2):103-10. PubMed ID: 22513515
[TBL] [Abstract][Full Text] [Related]
12. Effects of intravenous EDTA treatment on serum parathyroid hormone (1-84) and biochemical markers of bone turnover.
Guldager B; Brixen KT; Jørgensen SJ; Nielsen HK; Mosekilde L; Jelnes R
Dan Med Bull; 1993 Nov; 40(5):627-30. PubMed ID: 8299406
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
[TBL] [Abstract][Full Text] [Related]
14. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.
Szulc P; Chapuy MC; Meunier PJ; Delmas PD
J Clin Invest; 1993 Apr; 91(4):1769-74. PubMed ID: 8473517
[TBL] [Abstract][Full Text] [Related]
15. Changes in calcium, PTH and 1,25(OH)2 vitamin D3 during tail-suspension in ovariectomized rats: effects of estrogen administration.
Ohmori S; Kanda K; Kawano S; Kambe F; Seo H
Environ Med; 2000 Dec; 44(2):75-8. PubMed ID: 12353529
[TBL] [Abstract][Full Text] [Related]
16. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation.
Giannini S; D'Angelo A; Carraro G; Antonello A; Di Landro D; Marchini F; Plebani M; Zaninotto M; Rigotti P; Sartori L; Crepaldi G
Clin Nephrol; 2001 Nov; 56(5):353-63. PubMed ID: 11758005
[TBL] [Abstract][Full Text] [Related]
17. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
18. Effects of steroid treatment on bone mineral metabolism in children with glucocorticoid-sensitive nephrotic syndrome.
Koşan C; Ayar G; Orbak Z
West Indian Med J; 2012 Sep; 61(6):627-30. PubMed ID: 23441359
[TBL] [Abstract][Full Text] [Related]
19. Prevention of hypercalciuria and stone-forming propensity during prolonged bedrest by alendronate.
Ruml LA; Dubois SK; Roberts ML; Pak CY
J Bone Miner Res; 1995 Apr; 10(4):655-62. PubMed ID: 7610938
[TBL] [Abstract][Full Text] [Related]
20. The effect of recombinant PTH(1-34) and PTH(1-84) on serum ionized calcium, 1,25-dihydroxyvitamin D, and urinary calcium excretion: a pilot study.
Piemonte S; Romagnoli E; Cipriani C; Fassino V; Del Fiacco R; Carnevale V; Scillitani A; D'Erasmo E; Tancredi A; Minisola S
Calcif Tissue Int; 2009 Oct; 85(4):287-92. PubMed ID: 19756348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
